A center for testing genome editing in rodents
MU Rodent Testing Center for Somatic Cell Genome Editing
This study is creating a special center to help scientists test new gene-editing treatments using rats and mice, making it easier to turn these discoveries into real help for people with diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-10773783 on NIH RePORTER |
What this research studies
This research focuses on developing a specialized center that provides testing services for genome editing technologies using rodent models, particularly rats and mice. The center aims to accelerate the translation of these technologies into clinical applications by offering access to a variety of rodent disease models and ensuring high-quality standards in animal care. The team involved has extensive expertise in animal modeling and comparative medicine, which will enhance the rigor and reproducibility of research outcomes. By facilitating the testing of genetic interventions, this center aims to support advancements in therapeutic strategies for human diseases.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with genetic disorders that may be targeted by genome editing therapies.
Not a fit: Patients with conditions that are not amenable to genetic interventions or those who do not have access to clinical trials may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective gene therapies for various human diseases.
How similar studies have performed: Other research has shown success in using rodent models for testing genome editing technologies, indicating that this approach is promising and not entirely novel.
Where this research is happening
Columbia, United States
- University of Missouri-Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Bryda, Elizabeth C — University of Missouri-Columbia
- Study coordinator: Bryda, Elizabeth C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.